Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX.
Kaga Y, Sunakawa Y, Kubota Y, Tagawa T, Yamamoto T, Ikusue T, Uto Y, Miyashita K, Toshima H, Kobayashi K, Hisamatsu A, Ichikawa W, Sekikawa T, Shimada K, Sasaki Y.
Kaga Y, et al. Among authors: sasaki y.
Oncotarget. 2016 Oct 11;7(41):67314-67320. doi: 10.18632/oncotarget.12007.
Oncotarget. 2016.
PMID: 27634903
Free PMC article.